Trial · NCT00500656
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Controlled Phase- Icatibant (Randomized Subjects ) | ||
| Total, all-cause mortality | Controlled Phase- Tranexamic Acid (Randomized Subjects) | ||
| Total, all-cause mortality | Controlled Phase- Icatibant (Subjects w/ Laryngeal Attack) | ||
| Total, all-cause mortality | Open Label Extension Phase- Icatibant (Previously Randomized) | ||
| Total, all-cause mortality | Open Label Extension Phase (Subjects w/ Laryngeal Attack) | ||
| Total, all-cause mortality | Open Label Extension Phase(Untreated Patients at the Baseline | ||
| Total, other adverse events | Controlled Phase- Icatibant (Randomized Subjects ) | 19 | 36 |
| Total, other adverse events | Controlled Phase- Tranexamic Acid (Randomized Subjects) | 16 | 38 |
| Total, other adverse events | Controlled Phase- Icatibant (Subjects w/ Laryngeal Attack) | 1 | 3 |
| Total, other adverse events | Open Label Extension Phase- Icatibant (Previously Randomized) | 31 | 44 |
| Total, other adverse events | Open Label Extension Phase (Subjects w/ Laryngeal Attack) | 1 | 2 |
| Total, other adverse events | Open Label Extension Phase(Untreated Patients at the Baseline | 4 | 8 |
| Total, serious adverse events | Controlled Phase- Icatibant (Randomized Subjects ) | 4 | 36 |
| Total, serious adverse events | Controlled Phase- Tranexamic Acid (Randomized Subjects) | 1 | 38 |
| Total, serious adverse events | Controlled Phase- Icatibant (Subjects w/ Laryngeal Attack) | 1 | 3 |
| Total, serious adverse events | Open Label Extension Phase- Icatibant (Previously Randomized) | 9 | 44 |
| Total, serious adverse events | Open Label Extension Phase (Subjects w/ Laryngeal Attack) | 1 | 2 |
| Total, serious adverse events | Open Label Extension Phase(Untreated Patients at the Baseline | 0 | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00500656/event-totals